Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT
NCT02027064
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
DRUG:
Interferon-alpha
Sponsor
Peking University People's Hospital